The US Food and Drug Administration (FDA) has announced that two companies are voluntarily recalling batches of ranitidine tablets and one company is voluntarily recalling lots of nizatidine tablets in the US.
Over the past several weeks, the U.S. Food and Drug Association (FDA) has communicated about the detection of an impurity known as N-nitrosodimethylamine (NDMA) in ...